O
Onkos Surgical
Biotech & Life Sciences · Parsippany-Troy Hills, United States · Founded 2015
Surgical oncology company that develops implants and instruments for musculoskeletal tumor patients MoreLess
Onkos Surgical is a medical technology company specializing in solutions for musculoskeletal oncology and complex orthopedic procedures. The company designs and manufactures implants and instruments tailored to the specific needs of surgeons treating bone cancer and other complex bone-related conditions. Its product portfolio includes advanced, personalized implants, some of which are created using 3D printing technology to precisely match a patient's anatomy. This approach aims to improve surgical outcomes and reduce complexity for orthopedic oncologists.
The company operates in the specialized medical device market, serving hospitals and surgical centers that perform musculoskeletal tumor surgeries. Its business model is centered on the sale of these high-value medical devices. By focusing on the distinct challenges of musculoskeletal oncology, Onkos Surgical addresses a niche segment of the orthopedics market that requires a high degree of customization and clinical expertise.
Keywords: musculoskeletal oncology, orthopedic implants, medical devices, surgical instruments, 3D printing, bone cancer, personalized medicine, orthopedic surgery, medtech, surgical oncology
Talent graph
Onkos Surgical's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Onkos Surgical has talent and traffic
team presence
across markets
Market sentiment
What the market is saying about Onkos Surgical
An AI-synthesized read of the highest-engagement posts about Onkos Surgical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Onkos Surgical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.



